Stéphane Barète

Hôpital Necker-Enfants Malades — France

Immunology and Microbiology · Life Sciences

50h-index6.9kcitations322works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mast cells and histamine(109), Urticaria and Related Conditions(62), Cutaneous lymphoproliferative disorders research(37), Eosinophilic Disorders and Syndromes(35), Autoimmune Bullous Skin Diseases(29)

Publications320 total

Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population‐Based Cohort
Allergy·2025· 1 citedOpen Access
Étude multicentrique rétrospective des effets indésirables immuno-induits du mogamulizumab chez les patients traités pour un lymphome T cutané (étude MOGA-Tox)
Annales de Dermatologie et de Vénéréologie - FMC·2025
Survenue de cancers cutanés après une introduction de bélumosudil pour une GVH chronique
Annales de Dermatologie et de Vénéréologie - FMC·2025
Carcinomes annexiels cutanés chez les patients transplantés d’organes solides : cohorte nationale de 67 cas
Annales de Dermatologie et de Vénéréologie - FMC·2025
Histiocytose non langerhansienne cutanée ALK+ traitée efficacement par alectinib
Annales de Dermatologie et de Vénéréologie - FMC·2025
Transplantation de cellules souches hématopoïétiques allogéniques dans les lymphomes T cutanés avancés : bénéfice confirmé sur la survie globale après un suivi prolongé
Annales de Dermatologie et de Vénéréologie - FMC·2025
VRH6 : éruption virale liée au HHV-6 chez des patients autogreffés, avec régression sous antiviral
Annales de Dermatologie et de Vénéréologie - FMC·2025
Real‐Life Efficacy and Safety of <scp>BRAF</scp> Inhibitors in Erdheim‐Chester Disease
American Journal of Hematology·2025Open Access
AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis
2025Open Access
Efficacy and safety results from the primary analysis of the pivotal summit trial: Bezuclastinib in adults with non-advanced systemic mastocytosis
Blood·2025Open Access
Avapritinib achieves deep and durable symptom control with a well-tolerated safety profile in ism: Long-term outcomes from pioneer
Blood·2025Open Access
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation
Journal of Allergy and Clinical Immunology·2025
French guidelines for the management of nonadvanced mastocytosis in adults
Orphanet Journal of Rare Diseases·2025Open Access
Overall survival after allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
European Journal of Cancer·2025
Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study
British Journal of Haematology·2025Open Access
MPN-577: Favorable Benefit-Risk Profile of Avapritinib in Indolent Systemic Mastocytosis Is Maintained After 3 Years of Therapy: Longer-Term Analysis of the PIONEER Study
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: MPN-1082 Identification of Clonal Mast Cell Disease in Patients With Anaphylaxis or Evidence of Systemic Mast Cell Activation: A Post Hoc Analysis From PROSPECTOR
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: MPN-577 Favorable Benefit-Risk Profile of Avapritinib in Indolent Systemic Mastocytosis Is Maintained After 3 Years of Therapy: Longer-Term Analysis of the PIONEER Study
Clinical Lymphoma Myeloma & Leukemia·2025
MPN-1082: Identification of Clonal Mast Cell Disease in Patients With Anaphylaxis or Evidence of Systemic Mast Cell Activation: A Post Hoc Analysis From PROSPECTOR
Clinical Lymphoma Myeloma & Leukemia·2025
Patient‐Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the <scp>PRISM</scp> Study
Clinical & Experimental Allergy·2025· 1 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Olivier Hermine(20), Olivier Lortholary(15), Patrice Dubreuil(14), Zahir Amoura(9), Camille Françès(9), Felipe Suárez(8), Marie‐Olivia Chandesris(8), M. Beylot‐Barry(7), Sylvie Fraïtag(7), Danielle Canioni(7), Gandhi Damaj(7), Sophie Georgin‐Lavialle(7), Catherine Grandpeix‐Guyodo(6), Michel Arock(6), Alain Moussy(6), Julien Haroche(6), O. Dereure(6), M. D’Incan(6), S. Oro(6), Jean‐François Emile(5)